Abstract | BACKGROUND: Abdominal and dyspeptic complaints, which are prominent symptoms in patients with peptic ulceration, are commonly reported in the general population. There are few reports of follow-up study of peptic ulcer therapies in which clinical outcome has been compared with symptom reporting in community controls. METHODS: Three populations of patients with peptic ulcer disease (patients who had elective proximal gastric vagotomy (PGV), those having PGV for emergency indications and those receiving medical treatment with H2-receptor antagonists) were included in a questionnaire survey and compared with a group of randomly selected community controls. RESULTS: The vagotomized patients reported fewer abdominal complaints (P = 0.0003) and fewer dyspeptic complaints lasting for more than 1 week (P = 0.05) than those treated medically. There was no significant difference between vagotomized patients and community controls in the reporting of abdominal (P = 0.2) or dyspeptic (P = 0.9) complaints. CONCLUSION: Taking abdominal complaints as the endpoint for former peptic ulcer treatment, surgical treatment with PGV seemed to be superior to therapy with H2-receptor antagonists and produced an almost identical level of complaints to that seen in the community population.
|
Authors | R O Lindsetmo, R Johnsen, A Revhaug |
Journal | The British journal of surgery
(Br J Surg)
Vol. 85
Issue 6
Pg. 845-9
(Jun 1998)
ISSN: 0007-1323 [Print] England |
PMID | 9667721
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Dyspepsia
(etiology)
- Emergencies
- Female
- Histamine H2 Antagonists
(therapeutic use)
- Humans
- Male
- Middle Aged
- Peptic Ulcer
(complications, drug therapy, surgery)
- Peptic Ulcer Hemorrhage
(etiology, surgery)
- Peptic Ulcer Perforation
(etiology, surgery)
- Prospective Studies
- Vagotomy
(adverse effects, methods)
|